These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 16836306)
41. Hock cleavage of cholesterol 5alpha-hydroperoxide: an ozone-free pathway to the cholesterol ozonolysis products identified in arterial plaque and brain tissue. Brinkhorst J; Nara SJ; Pratt DA J Am Chem Soc; 2008 Sep; 130(37):12224-5. PubMed ID: 18722442 [TBL] [Abstract][Full Text] [Related]
42. Masakatsu Shibasaki. Shibasaki M Angew Chem Int Ed Engl; 2009; 48(38):6944-6. PubMed ID: 19722246 [No Abstract] [Full Text] [Related]
43. Organic synthesis in a changing world. Ley SV; Baxendale IR Chem Rec; 2002; 2(6):377-88. PubMed ID: 12469349 [TBL] [Abstract][Full Text] [Related]
44. Greener and sustainable approaches to the synthesis of pharmaceutically active heterocycles. Polshettiwar V; Varma RS Curr Opin Drug Discov Devel; 2007 Nov; 10(6):723-37. PubMed ID: 17987524 [TBL] [Abstract][Full Text] [Related]
45. [Stereochemistry and drug effects--a neglected field of knowledge]. Reis M; Kugelberg FC; Carlsson B; Josefsson M; Waldeck B Lakartidningen; 2006 Apr 26-May 2; 103(17):1305-6, 1309-11. PubMed ID: 16708858 [No Abstract] [Full Text] [Related]
46. Are pharmaceutics really going supercritical? Pasquali I; Bettini R Int J Pharm; 2008 Dec; 364(2):176-87. PubMed ID: 18597957 [TBL] [Abstract][Full Text] [Related]
47. Overview of chemical diversity. Triggle DJ Curr Protoc Pharmacol; 2001 May; Chapter 9():Unit 9.1. PubMed ID: 21971814 [No Abstract] [Full Text] [Related]
48. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence? Griffen EJ; Dossetter AG; Leach AG; Montague S Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971 [TBL] [Abstract][Full Text] [Related]
49. Air-dictated bottom spray process: impact of fluid dynamics on granule growth and morphology. Liew CV; Er DZ; Heng PW Drug Dev Ind Pharm; 2009 Jul; 35(7):866-76. PubMed ID: 19466895 [TBL] [Abstract][Full Text] [Related]
50. CHEMICAL SYNTHESIS. Going with the flow. Martin RE Science; 2016 Apr; 352(6281):44-5. PubMed ID: 27034365 [No Abstract] [Full Text] [Related]
51. Multicomponent reactions in solid-phase synthesis. Banfi L; Guanti G; Riva R; Basso A Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522 [TBL] [Abstract][Full Text] [Related]
52. Identification of the cellular targets of bioactive small organic molecules using affinity reagents. Leslie BJ; Hergenrother PJ Chem Soc Rev; 2008 Jul; 37(7):1347-60. PubMed ID: 18568161 [TBL] [Abstract][Full Text] [Related]
53. Organic synthesis in flow for medicinal chemistry. Wirth T Bioorg Med Chem; 2017 Dec; 25(23):6179. PubMed ID: 29153554 [No Abstract] [Full Text] [Related]
55. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances. Bao Y; Mo X; Xu X; He Y; Xu X; An H J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459 [TBL] [Abstract][Full Text] [Related]
56. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis. Carrier D; Eckers C; Arnoult T; Thurston T; Major H Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854 [No Abstract] [Full Text] [Related]
57. Theme issue "Solid state and solid dosage forms". Kleinebudde P Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869 [No Abstract] [Full Text] [Related]
58. Designing active template molecules by combining computational de novo design and human chemist's expertise. Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122 [TBL] [Abstract][Full Text] [Related]